These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12508608)

  • 1. Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease.
    Crawford TJ; Bennett D; Lekwuwa G; Shaunak S; Deakin JF
    Prog Brain Res; 2002; 140():449-66. PubMed ID: 12508608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory control and spatial working memory: a saccadic eye movement study of negative symptoms in schizophrenia.
    Winograd-Gurvich C; Fitzgerald PB; Georgiou-Karistianis N; Millist L; White O
    Psychiatry Res; 2008 Jan; 157(1-3):9-19. PubMed ID: 17897722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Working memory and the suppression of reflexive saccades.
    Mitchell JP; Macrae CN; Gilchrist ID
    J Cogn Neurosci; 2002 Jan; 14(1):95-103. PubMed ID: 11798390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can research on schizophrenia tell us about the cognitive neuroscience of working memory?
    Barch DM
    Neuroscience; 2006 Apr; 139(1):73-84. PubMed ID: 16300901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impairments of action control in the context of neuropsychological findings in schizophrenia].
    Reuter B; Kathmann N
    Fortschr Neurol Psychiatr; 2007 Oct; 75(10):607-16. PubMed ID: 17380466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia.
    Reuter B; Kathmann N
    Acta Psychol (Amst); 2004; 115(2-3):255-69. PubMed ID: 14962403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges.
    Cohen JD; Braver TS; O'Reilly RC
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1515-27. PubMed ID: 8941963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?
    Donohoe G; Reilly R; Clarke S; Meredith S; Green B; Morris D; Gill M; Corvin A; Garavan H; Robertson IH
    J Int Neuropsychol Soc; 2006 Nov; 12(6):901-6. PubMed ID: 17064452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERP indices of persisting and current inhibitory control: a study of saccadic task switching.
    Mueller SC; Swainson R; Jackson GM
    Neuroimage; 2009 Mar; 45(1):191-7. PubMed ID: 19100841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive control of saccadic eye movements.
    Hutton SB
    Brain Cogn; 2008 Dec; 68(3):327-40. PubMed ID: 19028265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in saccadic eye-movement control in Parkinson's disease.
    Chan F; Armstrong IT; Pari G; Riopelle RJ; Munoz DP
    Neuropsychologia; 2005; 43(5):784-96. PubMed ID: 15721191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B; Rakusan L; Kathmanna N
    Psychiatry Res; 2005 May; 135(1):1-10. PubMed ID: 15893384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in antisaccade task performance: inhibitory control or working-memory engagement?
    Eenshuistra RM; Ridderinkhof KR; van der Molen MW
    Brain Cogn; 2004 Nov; 56(2):177-88. PubMed ID: 15518934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccadic hypometria in drug-naive and drug-treated schizophrenic patients: a working memory deficit?
    Hutton SB; Cuthbert I; Crawford TJ; Kennard C; Barnes TR; Joyce EM
    Psychophysiology; 2001 Jan; 38(1):125-32. PubMed ID: 11321613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients.
    Amador SC; Hood AJ; Schiess MC; Izor R; Sereno AB
    Neuropsychologia; 2006; 44(8):1475-82. PubMed ID: 16376954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposing the neural correlates of antisaccade eye movements using event-related FMRI.
    Ettinger U; Ffytche DH; Kumari V; Kathmann N; Reuter B; Zelaya F; Williams SC
    Cereb Cortex; 2008 May; 18(5):1148-59. PubMed ID: 17728263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in non-demented Parkinson's disease patients: controlled and automatic behavior.
    Koerts J; Leenders KL; Brouwer WH
    Cortex; 2009 Sep; 45(8):922-9. PubMed ID: 19327762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease.
    Crawford TJ; Higham S; Renvoize T; Patel J; Dale M; Suriya A; Tetley S
    Biol Psychiatry; 2005 May; 57(9):1052-60. PubMed ID: 15860346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: Cognition and saccadic eye movements.
    Fielding J; Kilpatrick T; Millist L; White O
    J Neurol Sci; 2009 Feb; 277(1-2):32-6. PubMed ID: 18977003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.